Hoeppner, Bettina B.

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Fava, M., Freeman, M. P., Flynn, M., Judge, H., Hoeppner, B. B., Cusin, C., Ionescu, D. F., Mathew, S. J., Chang, L. C., Iosifescu, D. V., et al. (2020) · Molecular Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 433

Determining the relative importance of the mechanisms of behavior change within Alcoholics Anonymous: a multiple mediator analysis

Kelly, J. F., Hoeppner, B., Stout, R. L., & Pagano, M. (2012) · Addiction

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 303

Emerging adult age status predicts poor buprenorphine treatment retention

Schuman-Olivier, Z., Weiss, R. D., Hoeppner, B. B., Borodovsky, J., & Albanese, M. J. (2014) · Journal of Substance Abuse Treatment

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 127

Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder

Schiff, D. M., Nielsen, T. C., Hoeppner, B. B., Terplan, M., Hadland, S. E., Bernson, D., Greenfield, S. F., Bernstein, J., Bharel, M., Reddy, J., et al. (2021) · American Journal of Obstetrics and Gynecology

Opioid Use Disorder TreatmentPrenatal Substance Exposure Effects

Cited by 69

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients

Fava, M., Johe, K., Ereshefsky, L., Gertsik, L. G., English, B. A., Bilello, J. A., Thurmond, L. M., Johnstone, J., Dickerson, B. C., Makris, N., et al. (2016) · Molecular Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 45

Offering Population-Based Tobacco Treatment in a Healthcare Setting

Rigotti, N. A., Bitton, A., Kelley, J. K., Hoeppner, B. B., Levy, D. E., & Mort, E. (2011) · American Journal of Preventive Medicine

Smoking Behavior and CessationSubstance Abuse Treatment and Outcomes

Cited by 42

Peer support for mood disorder: Characteristics and benefits from attending the Depression and Bipolar Support Alliance mutual-help organization

Kelly, J. F., Hoffman, L., Vilsaint, C., Weiss, R., Nierenberg, A., & Hoeppner, B. (2019) · Journal of Affective Disorders

Mental Health and Patient InvolvementMental Health Treatment and Access

Cited by 30

Young adults with co-occurring disorders: substance use disorder treatment response and outcomes

Bergman, B. G., Greene, M. C., Slaymaker, V., Hoeppner, B. B., & Kelly, J. F. (2014) · Journal of Substance Abuse Treatment

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 28